P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: Prospects for reversing transport-dependent anthelmintic resistance.
about
A research agenda for helminth diseases of humans: intervention for control and eliminationDifferential Gene Expression across Breed and Sex in Commercial Pigs Administered Fenbendazole and Flunixin MeglumineGenome-wide SNP analysis using 2b-RAD sequencing identifies the candidate genes putatively associated with resistance to ivermectin in Haemonchus contortusGenetic variants and increased expression of Parascaris equorum P-glycoprotein-11 in populations with decreased ivermectin susceptibilityTrichuris suis and Oesophagostomum dentatum show different sensitivity and accumulation of fenbendazole, albendazole and levamisole in vitroInhibition or knockdown of ABC transporters enhances susceptibility of adult and juvenile schistosomes to PraziquantelCodelivery of chemotherapeutics via crosslinked multilamellar liposomal vesicles to overcome multidrug resistance in tumorMacrocyclic lactones differ in interaction with recombinant P-glycoprotein 9 of the parasitic nematode Cylicocylus elongatus and ketoconazole in a yeast growth assayMulti-Drug Resistance Transporters and a Mechanism-Based Strategy for Assessing Risks of Pesticide Combinations to Honey BeesIncreased expression of ATP binding cassette transporter genes following exposure of Haemonchus contortus larvae to a high concentration of monepantel in vitroIvermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safetyPolymorphism in ABC transporter genes of Dirofilaria immitis.Genomic introgression mapping of field-derived multiple-anthelmintic resistance in Teladorsagia circumcinctaGene expression analysis of ABC transporters in a resistant Cooperia oncophora isolate following in vivo and in vitro exposure to macrocyclic lactones.Moxidectin and the avermectins: Consanguinity but not identity.Schistosome ABC multidrug transporters: From pharmacology to physiology.Recent advances in candidate-gene and whole-genome approaches to the discovery of anthelmintic resistance markers and the description of drug/receptor interactions.Resistance to the macrocyclic lactone moxidectin is mediated in part by membrane transporter P-glycoproteins: Implications for control of drug resistant parasitic nematodes.A burst of ABC genes in the genome of the polyphagous spider mite Tetranychus urticae.Ion channels and drug transporters as targets for anthelmintics.Genetic blueprint of the zoonotic pathogen Toxocara canis.Synergistic inhibition of Haemonchus contortus exsheathment by flavonoid monomers and condensed tanninsABC multidrug transporters in schistosomes and other parasitic flatwormsPlasmalogen enrichment in exosomes secreted by a nematode parasite versus those derived from its mouse host: implications for exosome stability and biology.New approaches for understanding mechanisms of drug resistance in schistosomesIn silico analysis of the binding of anthelmintics to Caenorhabditis elegansP-glycoprotein 1.Lipid-like properties and pharmacology of the anthelmintic macrocyclic lactones.Polymorphism in ion channel genes of Dirofilaria immitis: Relevant knowledge for future anthelmintic drug design.Hurdles in selection process of nanodelivery systems for multidrug-resistant cancer.Cytochrome P450/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiae.In Vitro and In Vivo Drug Interaction Study of Two Lead Combinations, Oxantel Pamoate plus Albendazole and Albendazole plus Mebendazole, for the Treatment of Soil-Transmitted Helminthiasis.Recent Research Progress in China on Haemonchus contortus.Comparative plasma and milk dispositions, faecal excretion and efficacy of per os ivermectin and pour-on eprinomectin in horses.ABC-B transporter genes in Dirofilaria immitis.shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines.Effects of in vitro exposure to ivermectin and levamisole on the expression patterns of ABC transporters in Haemonchus contortus larvae.Drug-efflux and target-site gene expression patterns in Haemonchus contortus larvae able to survive increasing concentrations of levamisole in vitroEstablishment of the Ivermectin Research for Malaria Elimination Network: updating the research agenda.Increased susceptibility of a triclabendazole (TCBZ)-resistant isolate of Fasciola hepatica to TCBZ following co-incubation in vitro with the P-glycoprotein inhibitor, R(+)-verapamil.Cyathostomine egg reappearance period following ivermectin treatment in a cohort of UK Thoroughbreds.
P2860
Q21562256-A6A75D9D-1898-466E-9C67-4C76280BCA72Q27318232-069ABDE4-AF56-4EDB-8B76-F9597978590FQ28468305-9C6D1862-AA37-4228-870B-D13120DE3A30Q28486843-215ED5FC-6171-4F05-BCB1-05BEEB008F24Q28541876-4F2839CE-0CA5-4F83-B035-CB92B1499E02Q28543846-C3FF9D69-E747-4E98-9B36-CC4F12523058Q28543911-EAD46A6B-FBF4-423E-BE55-8D2AE1B06AF7Q28545804-CBFB48D1-4F6D-4C8F-9E58-4A02D40468DAQ28553082-A856EA7E-7DE1-4F12-A189-1819FC61F156Q28828547-1625517F-8F2F-4213-A093-D0730B4A8E50Q33593852-2FB920EE-9C49-48CD-8A1C-2A98E5ABA72DQ33648348-6DA53919-FEBA-4567-A7B8-F42A9F95A26CQ33897920-9830C1B1-3911-47E5-A8A5-0D5114ECAAD0Q34320393-4460209D-BAC1-491F-B6B7-BCAF9763FA10Q34404748-17C27C0D-D387-4A6A-B258-10D0F5044BD4Q34705514-FC80462E-CC44-41D3-B312-68BCC4D54C6AQ34705912-0E3C59D1-BA4A-4C9E-AD0B-D40D57E2E4C6Q34705924-926BBEE9-C9BD-4A37-B07B-6E3E9A85D244Q34714547-96FFB62D-6823-4E57-8206-AC0CAB109029Q34782668-82BD51B9-AB2C-434D-A3E2-9139F98502DEQ35081761-B540DE77-39D6-43B3-ADDF-82FB73A7956BQ35864891-AE51CAC5-CE8A-40A7-AADD-427107EB0163Q37053762-C1128E99-A28F-44E4-8B56-6EF6F6802D77Q37077489-C0937BCC-A30B-40C3-A6D1-CA53A4BBBDB6Q37177725-C4F8F291-4CAF-4402-A8FF-A62B47C74F7AQ37541732-28FFE9A3-810D-4DCA-BD7A-BFA48DF4166AQ38139573-81BE171D-91F4-48BC-8112-2C270F827272Q38816689-DA9E9012-7050-4551-A20A-6801347AB020Q38818166-8937D144-17C9-45A1-B6F6-214D01C08471Q38936568-D5630868-36E4-402B-B408-3CAE01FDD778Q38955207-11A9FB81-ABB2-49EE-8EA2-5502601D2667Q40052027-B5AA179A-E658-4EDB-8C2F-DBEA8F8FDB7CQ40471598-CAD9F569-0FB1-4615-BBE3-11E0CCEAB575Q40680363-0D28E2CC-3CF4-418D-A274-DB82FB9D9E08Q40926188-B358DEE3-E419-4E7E-AF45-FA86FD13D9A0Q41985572-C5457DC6-FCA6-48AA-93C4-454A8EBCEA36Q41986089-AD3BD30D-02D3-4D8E-A44C-6EE048B4D503Q42414575-E2A5E40E-8483-487C-AE18-4F77295A5979Q43788758-1DA1373C-E22C-4E7B-88D0-73A3616802ECQ48164094-A810E2D2-1C42-41A3-A796-FE3194FBFEA0
P2860
P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: Prospects for reversing transport-dependent anthelmintic resistance.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
P-glycoproteins and other mult ...... ndent anthelmintic resistance.
@en
P-glycoproteins and other mult ...... ndent anthelmintic resistance.
@nl
type
label
P-glycoproteins and other mult ...... ndent anthelmintic resistance.
@en
P-glycoproteins and other mult ...... ndent anthelmintic resistance.
@nl
prefLabel
P-glycoproteins and other mult ...... ndent anthelmintic resistance.
@en
P-glycoproteins and other mult ...... ndent anthelmintic resistance.
@nl
P2093
P2860
P1476
P-glycoproteins and other mult ...... ndent anthelmintic resistance.
@en
P2093
Anne Lespine
Catherine Bourguinat
Cécile Ménez
Roger K Prichard
P2860
P356
10.1016/J.IJPDDR.2011.10.001
P577
2011-11-07T00:00:00Z